News

  • NWO has announced that in the context of the ‘Fonds Nieuwe Chemische Innovaties’ (NCI), they have granted a subsidy for the collaboration between Maastricht University and SABIC for the research on polymer membranes on the basis of renewable copolymers.

  • Since the Biobased Materials Research group started on the Brightlands Chemelot Campus in 2013 the expansion of the group has been astounding.

  • Obese people run a higher risk of developing pneumonia, according to a PhD study conducted by Niki Ubags of Maastricht UMC+.


  • Patients suffering from Parkinson's disease showed no deficits in their ability to recognise emotions, while this ability was expected to be compromised. 

  • On March 4 the Supreme Court has decided that the 150-km radius criterion is in accordance with EU law, and is not discriminatory or an impediment of the free movement of workers.

  • Students or staff members here in Maastricht or in Brussels who experience any problems (logistical or otherwise) in connection with, or in the wake of, the attacks in Brussels can report to the Student Deans of Maastricht University. 

  • Placeholder

    Attacks Brussels

    The Executive Board of Maastricht University is deeply shocked by the attacks in Brussels. Hard on the heels of the tragic events in Paris, the heart of the European community has now become the target of horrific terror. On behalf of the entire academic community, our thoughts are with the victims...

  • A quartet of Finance in Motion staff members have introduced the basics of impact investing to students at a Dutch university, and they responded with pitches for a wide range of funds.

  • Mark Levels (ROA and GSBE) won a research grant in the highly competitive Open Research Area grant scheme, organized by NWO, ANR, JSPS, DFG and ESRC, to conduct a large cross-national research program on youth Not in Employment, Education and Training (NEETs).

  • On the 17th of March Professor Carl Figdor accepted the TEFAF Oncology Chair, a special professorship for scientists with an exceptional reputation in the field of cancer research.